Global Regulatory News and Updates

This podcast episode delivers comprehensive updates on regulatory changes and initiatives in the fields of securities, psychedelic drugs including ibogaine, and critical societal functions (Samhällsviktig verksamhet) and civil defense (Civilförsvar). It highlights global regulatory activities impacting multiple sectors and jurisdictions.

Key highlights include ESMA’s Call for Evidence on tokenised collateral in central clearing, inviting stakeholders to address legal and market challenges associated with tokenisation models. This initiative aims to understand operational resilience and settlement finality without altering collateral eligibility categories.

In Sweden, a landmark law focused on strengthening resilience among critical societal functions is set to take effect, promoting collaboration across public and private sectors to better manage crises, cyber threats, and extreme weather events. This law is supported by a national strategy for 2026–2030 emphasizing risk management and crisis preparedness.

Additionally, the FDA in the United States has issued a Request for Information to gather public input on ibogaine research, addressing study design, dosing, and safety monitoring protocols for cardiac and neurologic adverse events. This marks a significant step in regulatory engagement with psychedelic drug research.

For more information, visit the Carver Agents website.

Articles mentioned: